Jackson Hole Capital Partners »

SPDR S&P Pharmaceuticals shares owned by Jackson Hole Capital Partners

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Jackson Hole Capital Partners from 13F filings

Historical chart of Jackson Hole Capital Partners investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Jackson Hole Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Jackson Hole Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7k 35 47.94

More positions owned by Jackson Hole Capital Partners

Alliance Resource Partners L Ut Ltd Part (ARLP)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Williams Companies (WMB)
Meta Platforms Cl A (META)
Amazon (AMZN)
Apollo Global Mgmt (APO)
Ishares Tr Core Msci Eafe (IEFA)
Riley Exploration Permian In (REPX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Abbvie (ABBV)
Enterprise Products Partners (EPD)

View all positions for Jackson Hole Capital Partners

Top funds holding SPDR S&P Pharmaceuticals

Morgan Stanley
Envestnet Asset Management
LPL Financial
First Citizens Bank & Trust
Envestnet Portfolio Solutions
Goldman Sachs Group
Susquehanna International
Wells Fargo & Company
Cetera Investment Advisers
Jpmorgan Chase & Co
CX Institutional
Wharton Business Group
Clark Capital Management Group
Bp Wealth Management
Bnp Paribas Arbitrage, Snc

View all funds holding SPDR S&P Pharmaceuticals